The Obama administration dropped the proposal for changing how Medicare pays for prescription drugs after resistance from pharmaceutical companies, many physicians and both sides of the aisle in Congress. The Medicare Part B Drug Payment Model would have altered physician payments to avoid incentives for prescribing higher-cost drugs.